IC
AURA icon

Inscription Capital’s Aura Biosciences AURA Stock Holding History

Inscription Capital’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+17,806
New +$102K 0.01% 671

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Inscription Capital's AURA Position: Q1 2026 in Review

Inscription Capital opened a new position in Aura Biosciences (AURA) in Q1 2026: 17,806 shares worth $119K. The stake represents 0.01% of the portfolio and ranks #671 among its holdings.

126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Inscription Capital held 17,806 shares of Aura Biosciences worth $119K as of Q1 2026.
  • Aura Biosciences was a new Inscription Capital position in Q1 2026.
  • Aura Biosciences made up 0.01% of Inscription Capital's portfolio in Q1 2026, its #671 holding.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.